Recursion Pharmaceuticals, Inc.
Salt Lake City, UT, US· latest recorded location
Recursion Pharmaceuticals, Inc. is named on 48 US grants and 84 published applications in this corpus. Its most frequent classification is G16B (Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or).
- Granted patents
- 48
- Published applications
- 84
- Inventors
- 254
- Granted in 2026 so far
- 15
- Most recent grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 1 | 3 |
| 2021 | 5 | 2 |
| 2022 | 4 | 11 |
| 2023 | 3 | 5 |
| 2024 | 9 | 5 |
| 2025 | 9 | 24 |
| 2026 | 15 | 34 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 132 documents
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or65
- G06FComputing and data processing41
- G16CComputational chemistry38
- G06NAI and machine learning29
- G06VImage and video recognition21
- G06TImage data processing or generation, in general19
- A61PTherapeutic uses of medicines17
- C07DHeterocyclic compounds16
- A61KMedicines and medical preparations12
- G01NInvestigating or analysing materials by determining their chemical or physical properties9
Recent patents
- Generating virtual perturbed cells utilizing a latent transfer perturbation neural network6 Oct 2026US 12,755,813 B1
- Detecting analysis model compatibilities with complex experiment designs to generate experiment design and analysis model compatibility graphical user interfaces15 Sep 2026US 12,737,284 B2
- Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacy15 Sep 2026US 12,738,081 B2
- MALT-1 modulators8 Sep 2026US 12,729,201 B2
- Methods and user interfaces for designing cell-based screening assay experiments23 Jun 2026US 12,663,916 B1
- Bicyclic heteroarylamides having gpr68 modulating activity8 Oct 2026US 2026/0308159 A1
- Utilizing molecular dynamics simulation models to determine binding free energy metrics from a corrected protein binding structure conformation and a corrected compound binding structure24 Sep 2026US 2026/0290498 A1
- Generating binding free energy utilizing intelligent restraints and lambda steps for molecular dynamics models24 Sep 2026US 2026/0290499 A1
- Utilizing masked autoencoder generative models to extract cellular response representation embeddings10 Sep 2026US 2026/0268118 A1
- Utilizing masked autoencoder generative models to extract cellular response representation embeddings10 Sep 2026US 2026/0269005 A1
Most cited
By later US patents
- Systems and methods for evaluating whether perturbations discriminate an on target effect15US 10,146,914 B12018
- Electronic monitor for experimental animals6US 10,918,078 B12021
- Experimental animal behavioral research methods and apparatuses6US 10,959,398 B12021
- Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddings5US 12,119,090 B12024
- Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacy4US 12,073,638 B12024